EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent advances in CAR T-cell engineering using synthetic biology: Paving the way for next-generation cancer treatment

Sangita Dey, Moodu Devender, Swati Rani, Rajan Kumar Pandey

Advances in Protein Chemistry and Structural Biology · 2024

DOI: 10.1016/bs.apcsb.2024.02.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Protein Chemistry and Structural Biology, 2024. Verfasst von Sangita Dey und 3 weiteren Autor:innen. Beteiligte Einrichtung: CSO Department, Cellworks Research India Pvt Ltd, Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Neoplasms, Synthetic Biology, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 187 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This book chapter highlights a comprehensive exploration of the transformative innovations in the field of cancer immunotherapy. CAR (Chimeric Antigen Receptor) T-cell therapy represents a groundbreaking approach to treat cancer by reprogramming a patient immune cells to recognize and destroy cancer cells. This chapter underscores the critical role of synthetic biology in enhancing the safety and effectiveness of CAR T-cell therapies. It begins by emphasizing the growing importance of personalized medicine in cancer treatment, emphasizing the shift from one-size-fits-all approaches to patient-specific solutions. Synthetic biology, a multidisciplinary field, has been instrumental in customizing CAR T-cell therapies, allowing for fine-tuned precision and minimizing unwanted side effects. The chapter highlights recent advances in gene editing, synthetic gene circuits, and molecular engineering, showcasing how these technologies are optimizing CAR T-cell function. In summary, this book chapter sheds light on the remarkable progress made in the development of CAR T-cell therapies using synthetic biology, providing hope for cancer patients and hinting at a future where highly personalized and effective cancer treatments are the norm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsSynthetic BiologyReceptors, Chimeric AntigenHumansImmunotherapy, AdoptiveT-LymphocytesGene EditingCell Engineering

Stichwörter der Autor:innen

CAR T-CellCancerSynthetic biologyTherapyTreatment

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • CSO Department, Cellworks Research India Pvt Ltd, Bengaluru, Karnataka, India.
  • Department of Animal Biology, School of Life Sciences, University of Hyderabad, Hyderabad, India.
  • ICAR, National Institute of Veterinary Epidemiology and Disease Informatics, Bengaluru, Karnataka, India.
  • Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden. Electronic address: rajan.kumar.pandey@ki.se.

Zitieren

APA

Dey, S., Devender, M., Rani, S., & Pandey, R. K. (2024). Recent advances in CAR T-cell engineering using synthetic biology: Paving the way for next-generation cancer treatment. Advances in Protein Chemistry and Structural Biology. https://doi.org/10.1016/bs.apcsb.2024.02.003

Vancouver

Dey S, Devender M, Rani S, Pandey RK. Recent advances in CAR T-cell engineering using synthetic biology: Paving the way for next-generation cancer treatment. Advances in Protein Chemistry and Structural Biology. 2024. doi:10.1016/bs.apcsb.2024.02.003

BibTeX
@article{Dey2024,
  author = {Dey, Sangita and Devender, Moodu and Rani, Swati and Pandey, Rajan Kumar},
  title = {Recent advances in CAR T-cell engineering using synthetic biology: Paving the way for next-generation cancer treatment},
  journal = {Advances in Protein Chemistry and Structural Biology},
  year = {2024},
  doi = {10.1016/bs.apcsb.2024.02.003}
}
Kostenlos starten →